Abiopharma

🔍 DICKERSON GARY E (Director)

Company: APPLIED MATERIALS INC /DE (AMAT)

Report Date: 2026-06-15

Detailed Transactions and Holdings:

• Sold 11,273 shares of Common Stock at $590.03 per share (Direct)
  Date: 2026-06-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,766,891.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 15,755 shares of Common Stock at $590.52 per share (Direct)
  Date: 2026-06-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,751,136.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 9,186 shares of Common Stock at $591.4 per share (Direct)
  Date: 2026-06-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,741,950.00 | transaction_form_type: 4 | Footnotes: F4
• Sold 10,411 shares of Common Stock at $592.18 per share (Direct)
  Date: 2026-06-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,731,539.00 | transaction_form_type: 4 | Footnotes: F5
• Sold 4,682 shares of Common Stock at $593.51 per share (Direct)
  Date: 2026-06-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,726,857.00 | transaction_form_type: 4 | Footnotes: F6
• Sold 4,535 shares of Common Stock at $594.74 per share (Direct)
  Date: 2026-06-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,722,322.00 | transaction_form_type: 4 | Footnotes: F7
• Sold 5,933 shares of Common Stock at $595.59 per share (Direct)
  Date: 2026-06-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,716,389.00 | transaction_form_type: 4 | Footnotes: F8
• Sold 13,505 shares of Common Stock at $596.82 per share (Direct)
  Date: 2026-06-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,702,884.00 | transaction_form_type: 4 | Footnotes: F9
• Sold 4,457 shares of Common Stock at $597.45 per share (Direct)
  Date: 2026-06-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,698,427.00 | transaction_form_type: 4 | Footnotes: F10
• Sold 2,426 shares of Common Stock at $598.56 per share (Direct)
  Date: 2026-06-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,696,001.00 | transaction_form_type: 4 | Footnotes: F11
• Sold 837 shares of Common Stock at $599.35 per share (Direct)
  Date: 2026-06-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,695,164.00 | transaction_form_type: 4 | Footnotes: F12
• Sold 17,000 shares of Common Stock (Direct)
  Date: 2026-06-16 | Code: G | equity_swap_involved: 0 | shares_owned_after: 1,678,164.00 | transaction_form_type: 4

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $590.00 to $590.16, inclusive. The reporting person undertakes to provide to Applied Materials, Inc. ("Applied"), any security holder of Applied, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price set forth in footnote 1 and footnotes 3 through 12 to this Form 4.
• F2: Increased number of shares reflects periodic payroll acquisitions under Employees' Stock Purchase Plan that are exempt under Rule 16a-3 and Rule 16b-3. Number of shares includes 379,244 performance share units and restricted stock units previously reported that in the future will be converted on a one-for-one basis into shares of Applied common stock upon vesting, which vesting is scheduled to occur as follows: (a) 66,063 restricted stock units are scheduled to vest in installments in December of 2026 through 2028, and (b) 313,181 performance share units are scheduled to vest in installments in December of 2026 through 2028, which number of shares is the target amount, and the actual number of shares that may vest ranges from 0% to 200% of the target amount, depending on achievement of specified performance goals (all vesting is subject to continued employment through each applicable vesting date).
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $590.00 to $590.99, inclusive.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $591.00 to $591.94, inclusive.
• F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $592.02 to $593.00, inclusive.
• F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $593.11 to $594.07, inclusive.
• F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $594.14 to $595.03, inclusive.
• F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $595.16 to $596.03, inclusive.
• F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $596.20 to $597.18, inclusive.
• F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $597.20 to $598.13, inclusive.
• F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $598.20 to $599.19, inclusive.
• F12: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $599.22 to $599.50, inclusive.